Browse > Article

A Study on Ways to Optimize the Period of Hospitalization During High-Dose $^{131}I$ Treatment of the Thyroid Cancer  

Baek, Seong-Min (Dept. of Nuclear Medicine Kosin University Gospel hospital)
Ko, Seong-Jin (Dept. of Radiological Science, College of Health Science, Catholic University of Pusan)
Kim, Chang-Soo (Dept. of Radiological Science, College of Health Science, Catholic University of Pusan)
Kim, Jung-Hoon (Dept. of Radiological Science, College of Health Science, Catholic University of Pusan)
Kang, Se-Sik (Dept. of Radiological Science, College of Health Science, Catholic University of Pusan)
Publication Information
Journal of radiological science and technology / v.33, no.3, 2010 , pp. 269-276 More about this Journal
Abstract
This study attempts to propose ways to optimize and improve the period of hospitalization for the radioiodine treatment by calculating the dose rate of patients treated with high-dose radioiodine by distance and time slot. As a result, 24 hours after the patient was treated with 100 mCi high-dose iodine, the dose rate was attenuated to $1,035{\mu}Sv/hr$ at the navel, to $109{\mu}Sv/hr$ at 50 cm, and to $33{\mu}Sv/hr$ at 100 cm. 24 hours after the patient was treated with 150 mCi high-dose iodine, the dose rate was attenuated to $637{\mu}Sv/hr$ at the navel, to $100{\mu}Sv/hr$ at 50 cm, and to $40{\mu}Sv/hr$ at 100 cm. 24 hours after the patient was treated with 180 mCi high-dose iodine, the dose rate was attenuated to $1,251{\mu}Sv/hr$ at the navel, $140{\mu}Sv/hr$ at 50 cm, and to $56{\mu}Sv/hr$ at 100 cm. In light of the current criterion for discharge recommended by the US Nuclear Regulatory Commission being $70.4{\mu}Sv/hr$, the present study indicates earlier discharge is feasible by applying a new scheme. This suggests that the proposed scheme in this study will help to solve the problem of shortage of treatment beds with the increasing trend of patients with thyroid cancer taken into consideration.
Keywords
Radioiodine; High-Dose; Thyroid cancer; Radiation therapy;
Citations & Related Records
Times Cited By KSCI : 3  (Citation Analysis)
연도 인용수 순위
1 International Commission on Radiological Protection, Age-dependent Doses to Members of the Public from Intake of Radionuclides, Part 2 Ingestion Dose Coefficients, ICRP Publication 67, Pergamon Press, Oxford, UK, 1993
2 International Commission on Radiological Protection, Individual Monitoring for Internal Exposure of Workers Replecement of ICRP Publication 54, ICRP Publication 78, Pergamon Press, Oxford, UK, 1997
3 Hurley J.R, Becker D.V: The use of radioiodine in the management of the tyroid cancer in freeman LM. Weissman HS. ed. Nuclear Medicine An-nual New York Raven Press, 329-84, 1983
4 이귀원: 고용량 방사성옥소(I-131) 치료환자의 피폭선량 저감화 연구, 방사선기술과학, 30(4), 435-442. 2007   과학기술학회마을
5 Harbert J.C: Nuclear Medicine Therapy. New York. Thieme Medical Publishers. 1987
6 AJM van VELZEN, C.R. Chemaly, Radioisotope production capabilities, Therapeutic radioisotope usage in Europe Expected trends in terms of research activities, European Commission, EUR 21874 EN-DG JRC - Institute for Energy - RADIOISOTOPE SURVEY. 2005
7 고창순: 핵의학, 서울, 고려의학, 1997
8 배기한, 김화중, 최재진, 이원국: 131I Therapy 입원환자의 선량률과 잔류량 및 배설률측정, 핵의학기술학회, 13(2), 47-52, 2009
9 International Commission on Radiological Protection. Individual Monitoring for Intakes of Radionuclides by Workers: Design and Interpretation. Oxford: Pergamon Press; ICRP Publication 54, 1987
10 교육과학기술부고시 제 2009-37호, 2009
11 Mazzaferri E.L, Jhiang S.M: Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med, 97, 418-28, 1994   DOI   ScienceOn
12 International Commission on Radiological Protection, "Individual Monitoring for Intakes of Radionuclides by Workers: Design and Interpretation," ICRP Publication 54, Pergamon Press, Oxford, UK, 1987
13 홍성운, 분화성: 갑상선암의 방사성옥소 치료, 대한핵의학회지, 34(4), 2000
14 International Commission on Radiological Protection: Radiation safety Aspects of Brachytherapy for Prostate Cancer using Permanently Implanted Source, ICRP Publication 98, Oxford OX5, UK, 2005
15 윤국노, 임석태, 문은하, 김진숙, 정영진, 김동욱, 정환정, 손명희: 분화갑상선암으로 갑상선전절제술 후 고용량 방사성요오드 치료와 Helicobacter pylori감염과의 임상적 유용성, Nucl Med Mol Imaging, 43(6), 572-576, 2009   과학기술학회마을
16 배상균: 갑상샘암의 방사성요오드 치료의 최신 지견, Nucl Med Mol Imaging, 40(2), 132-140, 2006   과학기술학회마을
17 Christoph R, Markus D, Markus K: Radio-iodine therapy in differentiated thyroid cancer: indications and procedures, Best Practice & Research Clinical Endocrinlolgy & Metabolism, 22(6), 989-1007, 2008   DOI   ScienceOn
18 배상균: 갑상선 질환의 방사성옥소 치료, 대한핵의학회 연수강좌, 제 21차, 11-18, 2001
19 2006-2007년 암발생률, 1993-2007년 암발생자의 암생존율, 2007년 암유병률 통계, 보건복지가족부, 중앙암등록본부, 2009